Flipkart enters crowded healthtech sector with SastaSundar acquisition Mumbai: The Flipkart Group has signed a deal to acquire a majority stake in online pharmacy Sastasundar Marketplace to launch its own healthcare business amid a pandemic-triggered consolidation in India’s healthtech industry. Flipkart Health+, as the new entity will be known, will leverage the Walmart Inc.-controlled company’s
PharmEasys parent firm API Holdings cut down its advertising and promotional expenses to Rs 235 crore, less than half of what it incurred on this account in FY22, while staff costs also eased 12% to Rs 1,283 crore.